Evidence map›Paper›PMID 40756650›Full record

ArticleOpen forum infectious diseases2025

Effectiveness of an Embedded Infectious Disease Screening, Treatment, and Prevention Intervention Within an Inpatient Substance Use Treatment Program.

Kelly E Dyer, Rebecca Russell, Rayek Nafiz, Angela Burdick-McPhee, Jean O'Neal, Tanajsia Mason, Danica Kuncio, Hannah Zellman, Margaret Lowenstein, Nancy Aitcheson and 2 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kelly E DyerUniversity of Pennsylvania Health System, Division of Infectious Diseases, Philadelphia, PA, USA.ORCID https://orcid.org/0009-0006-2530-0191
Rebecca RussellUniversity of Pennsylvania Health System, Division of General Internal Medicine, Philadelphia, PA, USA.
Rayek NafizUniversity of Pennsylvania Health System, Division of Psychiatry, Philadelphia, PA, USA.ORCID https://orcid.org/0009-0005-1128-2562
Angela Burdick-McPheeUniversity of Pennsylvania Health System, Division of Psychiatry, Philadelphia, PA, USA.ORCID https://orcid.org/0000-0003-4800-4425
Jean O'NealUniversity of Pennsylvania Health System, Division of Infectious Diseases, Philadelphia, PA, USA.
Tanajsia MasonPhiladelphia Department of Public Health, Philadelphia, PA, USA.
Danica KuncioPhiladelphia Department of Public Health, Philadelphia, PA, USA.ORCID https://orcid.org/0000-0002-0777-5074
Hannah ZellmanHealth Federation of Philadelphia, PA, USA.
Margaret LowensteinUniversity of Pennsylvania Health System, Division of General Internal Medicine, Philadelphia, PA, USA.
Nancy AitchesonUniversity of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.ORCID https://orcid.org/0000-0002-3592-1905
Vincent Lo ReUniversity of Pennsylvania Health System, Division of Infectious Diseases, Philadelphia, PA, USA.ORCID https://orcid.org/0000-0001-7955-0600
Jessie TorgersenUniversity of Pennsylvania Health System, Division of Infectious Diseases, Philadelphia, PA, USA.ORCID https://orcid.org/0000-0002-7861-1421

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: People with substance use disorders (SUDs) are at higher risk for infectious diseases (IDs). Co-locating ID screening services within inpatient SUD treatment programs may decrease barriers to care; however, the impact of such screening has not been evaluated. Methods: We conducted an effectiveness study evaluating comprehensive ID screening within an 18-bed inpatient SUD program. During usual care (September 2021-June 2022), ID screening was completed at the discretion of the admitting psychiatrist. During the intervention (September 2022-June 2023), an ID-trained nurse met with patients to support completion of screening for HIV, viral hepatitis (hepatitis A [HAV], B [HBV], and C [HCV]), latent tuberculosis [LTBI], and sexually transmitted infections [STI]. Hepatitis vaccinations, HIV preexposure prophylaxis, and/or ID treatments were offered during admission. Results: Demographics were similar between the groups (n = 261, usual care; n = 207, intervention). Screening for ≥1 ID increased significantly during the intervention (60.2% vs 90.8%, Conclusions: Comprehensive ID screening within inpatient SUD programs can increase uptake of testing and facilitate low-barrier delivery of preventive and therapeutic treatment.

Indexed as

harm reductioninfectious diseasessubstance use disordervaccination uptakeviral hepatitis

Identifiers

PMID40756650
PMCPMC12314491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.